while the most prevalent red cell enzyme disorder is G6PD deficiency. [27] A definitive diagnosis of sickle cell anemia requires Hb electrophoresis and a demonstration of a sickle cell trait in ...

If a person with G6PD deficiency develops hemolytic anemia, a prompt blood transfusion may benefit them. The outcome of ...

KODATEF is not approved for use in the U.S. Demand for ARAKODA has been steadily growing in recent months as awareness and use of the product has expanded across the U.S. The Company is taking the ...

Hemolytic Anemia: G6PD testing must be performed before prescribing ARAKODA® due to the risk of hemolytic anemia. Monitor patients for signs or symptoms of hemolysis. G6PD Deficiency in Pregnancy ...

Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with a ...

Caution in those with G6PD deficiency; may be susceptible to oxidative hemolysis and increased potential to develop hemolytic anemia. There are no adequate and well-controlled studies in pregnant ...

Folate or G6PD deficiency. Severe allergy or bronchial ... blood dyscrasias (eg, megaloblastic anemia), hemolysis, hepatic or renal toxicity, crystalluria, pancreatitis, photosensitivity, drug ...

Hemolytic Anemia: G6PD testing must be performed before prescribing ARAKODA® due to the risk of hemolytic anemia. Monitor patients for signs or symptoms of hemolysis. G6PD Deficiency in ...